Login
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Generate password
Customer Guest
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approv...more...
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Opportunity to Shareholders Su...more...
The Exchange had sought clarification from Bal Pharma Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Ob...more...
Bal Pharma Limited has informed the Exchange regarding Corrigendum to The Postal Ballot Notice dated 09th July 2026. The corrigendum shall f...more...
In Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.more...
As of June 2026 50.86% is owned by Promoters and 49.14% by Public. Among Promoters holding Indian Promoters holds 46.75% and Foreign Promote...more...
Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2026more...
Bal Pharma Limited has informed the Exchange regarding Notice of Postal Ballot for consider the issue of 10 00 000 Warrants to Mr. Shailesh Siroya Pr...more...
Postal Ballot Notice for consider the issue of 1000000 Warrants to Mr. Shailesh Siroya promoter of the Company on preferential basismore...
Bal Pharma Limited has informed the Exchange regarding Mr. Shreepada ML has taken charge and commenced his duties as the Company Secretary and Compli...more...
This is with reference to our earlier intimation dated 27th May 2026 regarding appointment of Mr. Shreepada ML as company secretary and comp...more...
Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
The Exchange has sought clarification from Bal Pharma Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (L...more...
Filing of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.more...
Bal Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 27 2026 recommended Final Dividend of Rs. 1....more...
Bal Pharma Limited has submitted to the Exchange the financial results for the period ended March 31 2026.more...
Audited financial results of the company for the quarter and financial year ended 31.03.2026.more...
Board of Directors of the Company has met today and transacted following business \r\n1. Approved audited financial results of the Company f...more...
BOARD MEETINGS Company Name : 3M India Date : 14-08-2026
Latest Videos